Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Equities research analysts at SVB Leerink cut their Q3 2023 earnings per share estimates for shares of Viking Therapeutics in a report released on Wednesday, July 26th. SVB Leerink analyst T. Smith now anticipates that the biotechnology company will post earnings per share of ($0.23) for the […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.02, Briefing.com reports. Viking Therapeutics’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.23) […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.02, Briefing.com reports. The firm’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.02, Briefing.com reports. Viking Therapeutics’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period […]
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) fell 5.5% during mid-day trading on Monday . The company traded as low as $14.50 and last traded at $14.51. 730,293 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 3,481,354 shares. The stock had previously closed at […]